Response to "NLRC5 germline variants and their potential role in eliciting an immune response in patients with cancer treated with immune checkpoint inhibitors" by Xiang-Yu Meng
=================================================================================================================================================================================

* Lilach Aizenbud
* David A Schoenfeld
* Jasmine I Caulfield
* Jacqueline E Mann
* Matthew R Austin
* Ana Luisa Perdigoto
* Kevan C Herold
* Harriet M Kluger